• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

角蛋白6、13和19。在头颈部鳞状细胞癌中的差异表达。

Keratins 6, 13 and 19. Differential expression in squamous cell carcinoma of the head and neck.

作者信息

Klijanienko J, el-Naggar A, De Braud F, Micheau C, Janot F, Luboinski B, Gentile A, Russo A, Cvitkovic E

机构信息

Institut Gustave-Roussy, Villejuif, France.

出版信息

Anal Quant Cytol Histol. 1993 Oct;15(5):335-40.

PMID:7505082
Abstract

One hundred forty-one head and neck squamous cell carcinomas were analyzed for keratin (K) 6, 13 and 19. Staining was evaluated by light microscopy (with or without grading) and image analyzer and expressed as a percentage of positive versus all tumor surface (PSA). Both techniques rendered strongly correlated results. Strong expression was noted in 108 carcinomas (76.1%) for K6, in 18 (12.7%) for K19 and in 21 (14.8%) for K13 (P = .001). One hundred thirty-six (96%) tumors were positive for K6, and their PSA ranged from 0.6% to 48.8%; K19, 48 cases (0.2-44%); K13, 59 (0.2-38.1%). Expression of K6 was related to differentiation. K19 was expressed mainly in moderately and poorly differentiated tumors, and K13 was manifest more in well-differentiated carcinomas or in keratinized areas of less-differentiated ones. Nineteen (13.38%) tumors were positive for both K13 and K19. K19 thus was related to tumor progression and K13 to differentiation. There was no correlation with tumor site or TNM category.

摘要

对141例头颈部鳞状细胞癌进行了角蛋白(K)6、13和19的分析。通过光学显微镜(有或无分级)和图像分析仪评估染色情况,并以阳性与所有肿瘤表面的百分比(PSA)表示。两种技术得出的结果高度相关。108例癌(76.1%)K6呈强表达,18例(12.7%)K19呈强表达,21例(14.8%)K13呈强表达(P = 0.001)。136例(96%)肿瘤K6呈阳性,其PSA范围为0.6%至48.8%;K19,48例(0.2 - 44%);K13,59例(0.2 - 38.1%)。K6的表达与分化有关。K19主要在中分化和低分化肿瘤中表达,K13在高分化癌或低分化癌的角化区域中表达更为明显。19例(13.38%)肿瘤K13和K19均呈阳性。因此,K19与肿瘤进展有关,K13与分化有关。与肿瘤部位或TNM分期无关。

相似文献

1
Keratins 6, 13 and 19. Differential expression in squamous cell carcinoma of the head and neck.角蛋白6、13和19。在头颈部鳞状细胞癌中的差异表达。
Anal Quant Cytol Histol. 1993 Oct;15(5):335-40.
2
Changes in keratin expression during malignant progression of transformed mouse epidermal keratinocytes.转化的小鼠表皮角质形成细胞恶性进展过程中角蛋白表达的变化。
Exp Cell Res. 1993 Jan;204(1):11-21. doi: 10.1006/excr.1993.1003.
3
Keratin 13 expression is linked to squamous differentiation in rabbit tracheal epithelial cells and down-regulated by retinoic acid.角蛋白13的表达与兔气管上皮细胞的鳞状分化相关,并受视黄酸下调。
Exp Cell Res. 1989 Jun;182(2):622-34. doi: 10.1016/0014-4827(89)90264-4.
4
Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.在口腔鳞状细胞癌患者中,很少能检测到Her2表达和基因扩增。
J Oral Pathol Med. 2014 Apr;43(4):304-8. doi: 10.1111/jop.12173. Epub 2014 Mar 20.
5
Immunohistochemical expression of keratins 6, 7, 8, 14, 16, 18, 19, and MNF-116 pancytokeratin in primary and metastatic melanoma of the head and neck.角蛋白6、7、8、14、16、18、19及MNF-116全细胞角蛋白在头颈部原发性和转移性黑色素瘤中的免疫组化表达
Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 May;121(5):510-9. doi: 10.1016/j.oooo.2015.11.016. Epub 2015 Dec 19.
6
Expression of DOG1 (Using SP31) in Poorly Differentiated Carcinoma of the Head and Neck.DOG1(使用SP31)在头颈部低分化癌中的表达
Anticancer Res. 2016 Jun;36(6):3117-22.
7
Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.口腔鳞状细胞癌患者中表皮生长因子受体(EGFR)的免疫组织化学和荧光原位杂交分析及其预后价值
J Oral Pathol Med. 2014 Mar;43(3):205-10. doi: 10.1111/jop.12111. Epub 2013 Sep 11.
8
Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.头颈部鳞状细胞癌中拓扑异构酶IIα的表达
Anticancer Res. 2000 Jan-Feb;20(1A):177-82.
9
Metallothionein immunoreactivity in head and neck carcinomas; special reference to clinical behaviors and chemotherapy responses.头颈部癌中的金属硫蛋白免疫反应性;特别提及临床行为和化疗反应。
Anticancer Res. 2000 Jan-Feb;20(1A):257-64.
10
Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.头颈部鳞状细胞癌中丝氨酸蛋白酶抑制剂B13(SERPINB13)表达下调与不良临床预后相关。
Int J Cancer. 2009 Oct 1;125(7):1542-50. doi: 10.1002/ijc.24507.

引用本文的文献

1
Identification of tumour-related proteins as potential screening markers by proteome analysis-protein profiles of human saliva as a predictive and prognostic tool.通过蛋白质组学分析鉴定肿瘤相关蛋白作为潜在的筛查标志物-人唾液蛋白质组学作为预测和预后工具。
EPMA J. 2014 Nov 28;5(1):20. doi: 10.1186/1878-5085-5-20. eCollection 2014.
2
Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis.头颈部鳞状细胞癌临床病理参数的预后价值:一项前瞻性分析。
Br J Cancer. 1996 Feb;73(4):531-8. doi: 10.1038/bjc.1996.92.